{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T03:17:41Z","timestamp":1770520661120,"version":"3.49.0"},"reference-count":78,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":3984,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Gastro and Hepatol"],"published-print":{"date-parts":[[1997,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The successful isolation of<jats:italic>Helicobacter pylori<\/jats:italic>from the stomachs of patients with gastritis and peptic ulcer has revolutionized our concepts of the pathogenesis of gastritis, peptic ulcer, gastric cancer and gastric B cell lymphoma. Eradication of<jats:italic>H. pylori<\/jats:italic>heals gastritis and<jats:italic>H. pylori<\/jats:italic>\u2010related peptic ulcer. After a successful cure of<jats:italic>H. pylori<\/jats:italic>infection, virtually no recurrence of duodenal ulcer is seen. However, treatment to cure the infection has proved difficult. Numerous clinical trials have been attempted, but as yet no ideal regimen has been identified. Monotherapies have many drawbacks and should be avoided. Dual therapies combining a proton pump inhibitor (PPI) and an antimicrobial agent provide higher eradication rates than those involving two antimicrobial agents. Bismuth\u2010based triple therapies are more effective than dual therapies in eradicating<jats:italic>H. pylori<\/jats:italic>infection. However, poor compliance and frequent adverse effects have made these combinations less favourable in clinical practice. Proton pump inhibitor\u2010based triple therapies have shown more consistent and higher eradication rates with a short duration of treatment, good patient compliance, fewer side effects, prompt symptom relief and fast ulcer healing. Results from PPI\u2010based quadruple therapies are promising; however, large multicentre clinical trials are needed to confirm the effect and the complex regimen again may compromise compliance outside of the clinical trial setting. Eradication of<jats:italic>H. pylori<\/jats:italic>infection is cost\u2010effective in the long\u2010term management of peptic ulcer disease compared with maintenance therapy with antisecretory drugs.<\/jats:p>","DOI":"10.1111\/j.1440-1746.1997.tb00491.x","type":"journal-article","created":{"date-parts":[[2008,3,10]],"date-time":"2008-03-10T22:48:32Z","timestamp":1205189312000},"page":"590-598","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["R<scp>eview:<\/scp>Eradication of Helicobacter pylori. Problems and recommendations"],"prefix":"10.1111","volume":"12","author":[{"given":"JIA\u2010QING","family":"HUANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RICHARD H","family":"HUNT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/archinte.1994.00420070021003","article-title":"Helicobacter pylori","volume":"154","author":"Fennerty MB.","year":"1994","journal-title":"Arch. Intern. Med."},{"issue":"2","key":"e_1_2_1_3_2","first-page":"59","article-title":"The prevalence of Helicobacter pylori in peptic ulcer disease.","volume":"9","author":"Kuipers EJ","year":"1995","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"2","key":"e_1_2_1_4_2","first-page":"71","article-title":"The prevalence of Helicobacter pylori infection in gastric cancer.","volume":"9","author":"Forman D.","year":"1995","journal-title":"Aliment. Pharmacol. Ther."},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-011-1418-9_48"},{"issue":"3","key":"e_1_2_1_6_2","first-page":"281","article-title":"Changes in the gastric mucosa following eradication of Helicobacter pylori.","volume":"6","author":"Genta RM","year":"1993","journal-title":"Modern Pathol."},{"issue":"4","key":"e_1_2_1_7_2","first-page":"A137","article-title":"Antibiotics accelerate healing of duodenal ulcer (DU) when combined with proton pump inhibitors (PPI) or H2\u2010receptor antagonists (H2RAs).","volume":"110","author":"Huang JQ","year":"1996","journal-title":"Gastroenterology"},{"issue":"10","key":"e_1_2_1_8_2","first-page":"1785","article-title":"Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection.","volume":"89","author":"Labenz J","year":"1994","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"e_1_2_1_9_2","first-page":"S67","article-title":"Effect of Helicobacter pylori eradication on the healing and recurrence of peptic ulcer: combination therapy with low\u2010dose omeprazole and clarithromycin.","volume":"7","author":"Uemura N","year":"1995","journal-title":"Europ. J. Gastroenterol. Hepatol."},{"issue":"4","key":"e_1_2_1_10_2","first-page":"A282","article-title":"Helicobacter pylori eradication inhibits the growth of intestinal type of gastric cancer in initial stage.","volume":"110","author":"Uemura N","year":"1996","journal-title":"Gastroenterology"},{"issue":"4","key":"e_1_2_1_11_2","first-page":"A490","article-title":"Regression of primary gastric lymphoma after cure of Helicobacter pylori infection: a two\u2010year follow\u2010up report.","volume":"110","author":"Bayerd\u00f6rffer E","year":"1996","journal-title":"Gastroenterology"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(96)80228-2"},{"issue":"12","key":"e_1_2_1_13_2","first-page":"1716","article-title":"Metaanalysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori.","volume":"87","author":"Chiba N","year":"1992","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-5378.1996.tb00003.x"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.30.3.510"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(96)80227-0"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90278-3"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529609094537"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1993.tb00121.x"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199510000-00012"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-120-12-199406150-00001"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-10-787"},{"key":"e_1_2_1_23_2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.1994.03520010077036","article-title":"NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease: Helicobacter pylori in peptic ulcer disease","volume":"272","year":"1994","journal-title":"JAMA"},{"issue":"4","key":"e_1_2_1_24_2","first-page":"A169","article-title":"Does treatment of Helicobacter pylori (Hp) with antibiotics alone heal duodenal ulcer (DU)? A randomized double blind placebo\u2010controlled study.","volume":"110","author":"Lam SK","year":"1996","journal-title":"Gastroenterology"},{"issue":"3","key":"e_1_2_1_25_2","first-page":"A142","article-title":"Does initial choice of Helicobacter pylori treatment regimen influence the recurrence rate of duodenal ulcer? A meta\u2010analysis.","volume":"39","author":"Huang JQ","year":"1996","journal-title":"Gut"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529409094856"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)23329-6"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(95)70267-9"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1159\/000201117"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529309098288"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5107(95)70266-0"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.155.18.1958"},{"key":"e_1_2_1_33_2","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/archinte.1995.00430090057007","article-title":"Costs of duodenal ulcer therapy with antibiotics","volume":"155","author":"Sonnenberg A","year":"1995","journal-title":"Arch. Intern. Med."},{"issue":"2","key":"e_1_2_1_34_2","first-page":"239","article-title":"Cost\u2010effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.","volume":"91","author":"Vakil N","year":"1996","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02735556"},{"key":"e_1_2_1_36_2","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1001\/jama.1996.03530320046033","article-title":"Practice Parameters Committee of the American College of Gastroenterology Consensus Statement: Medical treatment of peptic ulcer disease","author":"Soll AH.","year":"1996","journal-title":"JAMA"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529609094532"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90007-8"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529609094541"},{"key":"e_1_2_1_40_2","first-page":"1860","article-title":"Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double\u2010blind trial","volume":"88","author":"Peterson WL","year":"1993","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"e_1_2_1_41_2","first-page":"S49","article-title":"Rationale for the choice of antibiotics for the eradication of Helicobacter pylori.","volume":"7","author":"M\u00e9graud F.","year":"1995","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1994.tb00303.x"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)90095-G"},{"key":"e_1_2_1_44_2","first-page":"505","article-title":"Patient factors affecting Helicobacter pylori eradication with triple therapy","volume":"88","author":"Cutler AF","year":"1993","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1992.tb00551.x"},{"key":"e_1_2_1_46_2","first-page":"1993","article-title":"Randomized study comparing 1 with 2 weeks of quadruple therapy for eradicating Helicobacter pylori.","volume":"89","author":"Boer WA","year":"1994","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91043-A"},{"key":"e_1_2_1_48_2","first-page":"A93","article-title":"Helicobacter pylori in Africa: Is there an Africa enigma?","volume":"56","author":"Willemin B","year":"1993","journal-title":"Acta Gastroenurol. Belg."},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1994.tb00304.x"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1159\/000200908"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02464960"},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01967591"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.28.9.1120"},{"key":"e_1_2_1_54_2","first-page":"1975","article-title":"Acid inhibition and amoxicillin activity against Helicobacter pylori.","volume":"88","author":"Savarino V","year":"1993","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.37.4.769"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02214869"},{"key":"e_1_2_1_57_2","first-page":"A176","article-title":"Gastric juice immunoglobulins\u2010immunophysiological interaction in Helicobacter pylori infection","volume":"104","author":"Rademaker JW","year":"1993","journal-title":"Gastroenterology"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529409091407"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529609094542"},{"key":"e_1_2_1_60_2","first-page":"697","article-title":"High dose omeprazole treatment combined with amoxicillin eradicates","volume":"4","author":"Bayerd\u00f6rffer E","year":"1992","journal-title":"H. pylori. Eur. J. Gastroenterol. Hepatol."},{"issue":"2","key":"e_1_2_1_61_2","first-page":"T124","article-title":"Clarithromycin (C) dual and triple therapies in H. pylori (Hp) eradication: A meta analysis.","volume":"37","author":"Chiba N","year":"1995","journal-title":"Gut"},{"key":"e_1_2_1_62_2","first-page":"98","article-title":"Cure of Helicobacter pylori infection: role of duration of treatment with omeprazole and amoxicillin","volume":"91","author":"Adamek RJ","year":"1996","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_1_63_2","first-page":"491","article-title":"Omeprazole plus amoxicillin: Efficacy of various treatment regimens to eradicate Helicobacter pylori.","volume":"88","author":"Labenz J","year":"1993","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"e_1_2_1_64_2","first-page":"S55","article-title":"Clarithromycin for treatment of Helicobacter pylori infections.","volume":"7","author":"Graham DY.","year":"1995","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.7.1496"},{"key":"e_1_2_1_66_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199244010-00009"},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.9.2078"},{"key":"e_1_2_1_68_2","first-page":"A17","article-title":"Dual therapy of clarithromycin (CL) and omeprazole (OM) for treatment of patients with duodenal ulcers (DU) associated with H. pylori (HP) infection","volume":"37","author":"Hunt RH","year":"1995","journal-title":"Gut"},{"key":"e_1_2_1_69_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00400.x"},{"key":"e_1_2_1_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)22981-7"},{"key":"e_1_2_1_71_2","first-page":"A459","article-title":"Lansoprazole amoxicillin versus omeprazole\/amoxicillin in H. pylori eradication","volume":"89","author":"Tyszkiewicz T","year":"1994","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_2_1_72_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00372.x"},{"key":"e_1_2_1_73_2","first-page":"44A","article-title":"Attempt by meta\u2010analysis to define the optimai treatment regimen for eradicating Helicobacter pylori (H. pylori) infection.","volume":"11","author":"Huang JQ","year":"1997","journal-title":"Can. J. Gastroenterol."},{"key":"e_1_2_1_74_2","first-page":"835","article-title":"Efficacy and optimum dose of omeprazole in a new one week triple therapy regimen to eradicate Helicobacter pylori.","volume":"7","author":"Moayyedi P","year":"1995","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"e_1_2_1_75_2","first-page":"A198","article-title":"One week low\u2010dose triple therapy for eradication of H pylori: a large multicentre, randomized trial","volume":"110","author":"Misiewucz JJ","year":"1996","journal-title":"Gastroenterology"},{"key":"e_1_2_1_76_2","first-page":"A4","article-title":"The MACH 1 study: optimal one\u2010week treatment for H. pylori defined?","volume":"37","author":"Lind T","year":"1995","journal-title":"Gut"},{"key":"e_1_2_1_77_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.727119000.x"},{"key":"e_1_2_1_78_2","first-page":"A55","article-title":"Optimal H. pylori therapy: A combination of omeprazole and triple therapy","volume":"106","author":"Borody TJ","year":"1994","journal-title":"Gastroenterology"},{"key":"e_1_2_1_79_2","first-page":"A284","article-title":"H. pylori reinfection after successful eradication analysed by RAPD or RELP","volume":"110","author":"Hulst RWM","year":"1996","journal-title":"Gastroenterology"}],"container-title":["Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1440-1746.1997.tb00491.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1440-1746.1997.tb00491.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T01:19:17Z","timestamp":1738113557000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1440-1746.1997.tb00491.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,8]]},"references-count":78,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1997,8]]}},"alternative-id":["10.1111\/j.1440-1746.1997.tb00491.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1440-1746.1997.tb00491.x","archive":["Portico"],"relation":{},"ISSN":["0815-9319","1440-1746"],"issn-type":[{"value":"0815-9319","type":"print"},{"value":"1440-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,8]]},"assertion":[{"value":"2008-06-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}